The Human-Specific and Smooth Muscle Cell-Enriched lncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling

Amira Mahmoud, Margaret Ballantyne, Vladislav Miscianinov, Karine Pinel, John Hung, Jessica Scanlon, Jean Iyinikkel, Jakub Kaczynski, Adriana Tavares, Angela Bradshaw, Nicholas Mills, David Newby, Andrea Caporali, Gwyn Gould, Sarah George, Igor Vlitsky, Judith Sluimer, Julie Rodor, Andrew Baker

Research output: Contribution to journalArticle (Academic Journal)

6 Citations (Scopus)
73 Downloads (Pure)

Abstract

Rationale: In response to blood vessel wall injury, aberrant proliferation of vascular smooth muscle cells causes pathologic remodelling. However, the controlling mechanisms are not completely understood.

Objective: We recently showed that the human long non-coding RNA, SMILR, promotes vascular smooth muscle cells (vSMCs) proliferation by a hitherto unknown mechanism. Here, we assess the therapeutic potential of SMILR inhibition and detail the molecular mechanism of action.

Methods and Results: We used deep RNA-sequencing of human saphenous vein smooth muscle cells stimulated with IL1α and PDGF-BB with SMILR-knockdown (siRNA) or -overexpression (lentivirus), to identify SMILR regulated genes. This revealed a SMILR-dependent network essential for cell-cycle progression. In particular, we found using the fluorescent ubiquitination-based cell cycle indicator viral system that SMILR regulates the late mitotic phase of the cell cycle and cytokinesis with SMILR knockdown resulting in ~10% increase in binucleated cells. SMILR-pulldowns further revealed its potential molecular mechanism, which involves an interaction with the mRNA of the late mitotic protein CENPF and the regulatory Staufen1 RNA-binding protein. SMILR and this downstream axis were also found to be activated in the human ex vivo vein graft pathological model and in primary human coronary artery smooth muscle cells and atherosclerotic plaques obtained at carotid endarterectomy. Finally, to assess the therapeutic potential of SMILR, we used a novel siRNA approach in the ex vivo vein graft model (within the 30 min clinical time frame that would occur between harvest and implant) to assess the reduction of proliferation by EdU incorporation. SMILR-knockdown led to a marked decrease in proliferation from ~29% in controls to ~5% with SMILR depletion.

Conclusion: Collectively, we demonstrate that SMILR is a critical mediator of vascular smooth muscle cell proliferation via direct regulation of mitotic progression. Our data further reveals a potential SMILRtargeting intervention to limit atherogenesis and adverse vascular remodelling.
Original languageEnglish
Pages (from-to)535 - 551
Number of pages17
JournalCirculation Research
Volume125 (2019)
Issue number5
DOIs
Publication statusPublished - 24 Jul 2019

Keywords

  • Long non-coding RNA;
  • vascular remodelling
  • Vascular smovoth muscle cells
  • cell cycle
  • proliferation
  • blood vessels
  • growth factors
  • interleukins
  • muscle cells
  • noncoding RNA
  • saphenous vein

Fingerprint Dive into the research topics of 'The Human-Specific and Smooth Muscle Cell-Enriched lncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling'. Together they form a unique fingerprint.

  • Cite this

    Mahmoud, A., Ballantyne, M., Miscianinov, V., Pinel, K., Hung, J., Scanlon, J., Iyinikkel, J., Kaczynski, J., Tavares, A., Bradshaw, A., Mills, N., Newby, D., Caporali, A., Gould, G., George, S., Vlitsky, I., Sluimer, J., Rodor, J., & Baker, A. (2019). The Human-Specific and Smooth Muscle Cell-Enriched lncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling. Circulation Research, 125 (2019)(5), 535 - 551. https://doi.org/10.1161/CIRCRESAHA.119.314876